Apparent diffusion coefficient and tumor volume measurements help stratify progression-free survival of bevacizumab-treated patients with recurrent glioblastoma multiforme.
Neuroradiol J
; 32(4): 241-249, 2019 Aug.
Article
in En
| MEDLINE
| ID: mdl-31066622
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Glioblastoma
/
Bevacizumab
/
Antineoplastic Agents, Immunological
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Neuroradiol J
Year:
2019
Type:
Article
Affiliation country:
Italy